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Introduction 
Gluteal tendinopathy (GT) is a condition characterized by lateral hip pain that is aggravated by 
weight bearing on the affected leg, pain with palpation over the greater trochanter and difficulty 
lying on the affected side. Tendinopathy of the gluteus medius and/or minimus tendon/s may be 
accompanied by changes in the adjacent bursae and fascia.[1-4] GT refers to pain associated with 
these local soft tissue sources of nociception and does not include referred pain from the trunk, 
abdomen, pelvis or lumbar spine. This condition is prevalent in older adults, particularly in peri- and 
post-menopausal women, with substantial impacts on quality of life [5] and healthcare demands. 
The number of studies investigating interventions targeting the population suffering with this 
condition is growing, and yet there is wide variation in both patient-rated and physical measures 
selected for evaluating outcomes. Selection of outcome measurement instruments that have not 
been recommended, developed or validated for use in specific populations, or selection of 
instruments from only a limited number of health-related outcome domains, may bias outcome 
reporting [6, 7]. Homogeneity in selection and reporting of outcomes is important for interpretation 
and comparison of outcomes of interventions [8]. This is critical for allowing meta-analyses which 
form the basis for evidence-informed practice [9] (Williamson et al 2017). Therefore, a need exists to 
define a core outcome set (COS) of validated outcome measures that evaluate established core 
health-related domains. 
A Delphi study of healthcare professionals and researchers with expertise in the field of 
tendinopathy, with additional consultation with patients with tendinopathy at varying anatomical 
locations, established a tendinopathy-specific core domain set of 9 items (patient rating of condition, 
participation in life activities, pain on activity/loading, function, psychological factors, physical 
function capacity, disability, quality of life and pain over a specified time) [10], providing the 
foundation for subsequent identification of a COS for specific tendinopathies. 
In order to develop and disseminate a COS specific for GT, a necessary first step is to identify all 
reported outcome measures currently used in studies of people with GT. Once identified, these 
instruments will be assessed for quality and fit to the previously identified outcome domains before 
undergoing a 3-stage Delphi process with two online surveys and a face-to-face consensus meeting 
of those healthcare professionals involved in studying and/or clinicians with recognised expertise in 
managing people with GT, as well as patients with GT, to establish the COS for GT. 
Objective 
This scoping review addresses the question of ‘What outcome measures have been used in 
evaluating people with Gluteal Tendinopathy?’ It aims to identify and provide an overview of the 
outcome measures used to assess and evaluate interventions in those with GT. This is a necessary 
first stage in the systematic development of a COS for GT. 
Ethics 
Since a scoping review aims at synthesizing information from available publications, this study does 
not require ethics approval. 
Protocol Design 
The scoping review will be informed by the framework recommended by the Joanna Briggs Institute 
[11], which provides recommendations for organisation of the review process, including an initial 
identification of the research question and then relevant studies, data extraction and presentation 
and interpretation of results. The research question for this study is:  
What outcome measures have been used in evaluating people with Gluteal Tendinopathy? 
Identifying relevant studies 
It is important to initially identify the criteria that will be used to select the studies for inclusion. 
Although this scoping review is designed to cover a very broad spectrum of literature, initial criteria 
will be established to help guide the search. 
Inclusion Criteria 
Types of participants 
In order to identify articles that will address the aims of this review, the included papers must 
indicate that a clinical diagnosis of GT has been made. Due to the discrepancies and development 
over the years of acceptable terminology for the condition, studies that use the terms GT, greater 
trochanteric pain syndrome, lateral hip pain, abductor tendinopathy and trochanteric bursitis will be 
included. The diagnosis may be a clinical diagnosis, with or without radiological confirmation. 
Participants in the studies must be aged 18 years and over, and studies must have a minimum 
sample size of ten participants.   
Concept 
As the objective of this scoping review is to identify all existing outcome measures employed in 
studies of people with GT, all studies that report the outcome measure used, or a specific outcome 
measurement instrument will be included. All outcome measures will be eligible for inclusion.  
The source of the information will be left open, in order to allow for the inclusion of all types of 
studies. Thus, the study design may include any of the following: 
 Randomised controlled trials, observational cohorts, single-arm intervention (cohort) studies, 
case series, longitudinal or prognostic studies, and systematic reviews (in order to cross check 
reference lists to identify further papers) 
 Protocol papers  
 Papers relating to the development of condition specific outcome measures.  
 Studies assessing impairments (e.g. Strength, kinetics, kinematics, electromyography and 
sensory impairments), or activity and participation limitations.  
 Any intervention studies in which a treatment outcome for GT has been measured, providing 
outcome measures are reported. Interventions may include (but are not limited to) 
advice/education, exercise, injection (corticosteroid, platelet rich plasma (PRP), autologous 
blood injection (ABI), stem cell injection), surgery, shockwave therapy, dry needling and 
medication.   
Context 
There will be no restriction on the context of the papers, thus any specific setting of research will be 
accepted (such as acute care, primary health care or the community). 
Exclusion criteria 
Papers in languages other than English will be excluded due to limited resources and the cost of 
funding for translation services. Additionally, when a full text article is not available for review, the 
paper will be excluded. 
Other types of papers that will be excluded include animal studies and in-vitro experiments, 
diagnostic utility papers, trial registrations, case reports, surgical technique papers, opinion pieces or 
clinical papers, studies that examine the risk of developing the condition (risk factor studies), papers 
that use only imaging (e.g. MRI, ultrasound) parameters as outcome measures, and papers that 
report on trochanteric pain or tendon pathology that is associated with infective or 
systemic/rheumatological conditions.  
Search Strategy 
The literature search will be performed by a librarian from the Biological Sciences Library, University 
of Queensland, Australia, who will help advise on the most appropriate Medical Subject Headings 
terms for the search and how they should be modified for the different databases. The search 
strategy will be as comprehensive as possible, to identify both published and unpublished (grey 
literature) studies, as well as reviews.  
Relevant key words and index terms will be identified and established and used to undertake 
searches across all relevant databases. These key words will be based on a brief preliminary review 
of key articles that encompass research on interventions for management of GT. 
The online data bases to be searched will be Cochrane, PubMed, EMBASE, Scopus, Web of Science, 
PEDro, CINAHL, and SPORTDiscus. In order to capture outcome measures reported in the grey 
literature, Proquest dissertations and Theses Global, NICE, OpenGrey, and Google will be searched. 
All identified articles will be collected in Endnote and imported into Covidence (a web-based 
software platform to streamline the production of systematic reviews: www.covidence.org).  
Duplicates will be removed firstly by using an inbuilt function in Endnote, then manual screening of 
the Endnote library by one of the reviewers, and finally after exporting into Covidence, using an 
inbuilt function.  
Study selection 
The initial screen will be by title and abstract examination, performed by members of the research 
team. Each article will be screened by two reviewers independently, and any disagreements will be 
resolved by a third reviewer. The selection of articles will be based on the pre-specified inclusion and 
exclusion criteria. For all articles appearing to fulfil the eligibility criteria, the full article will be 
retrieved.  
Full texts will then be examined by two independent reviewers, and any disagreements will be 
resolved firstly by discussion and if necessary, a third reviewer will be decisive. Additionally, the 
reference lists of the included full text articles will be examined to determine if any relevant study 
has not previously been identified by the search.  
The process of the study selection will be reported using a Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses flow chart (PRISMA) [12].  
The search strategy for some of the included data bases has been included as an appendix.  
Data Extraction 
Once all relevant articles have been identified, the data extraction process will be performed by all 
members of the team of researchers. A draft charting table has been developed in Excel in order to 
record key information from the identified studies. It is likely that this table will be further refined 
throughout the process of review and updated as necessary. (Appendix X)  
In addition to standard bibliographical information (e.g. author, title, journal, year of publication), 
for each article, information on the characteristics of the study populations, definitions of the 
outcomes measured and the outcome measurement instruments used, how they were obtained and 
any information on the validity of the outcome measures will be obtained.  Contact information for 
the corresponding author/s will also be extracted in order to contact researchers in this field for the 
subsequent Delphi process.  
Key information that will initially be charted includes: 
 
 Authors 
 Year of publication 
 Title 
 Contact details of corresponding author 
 Journal/source  
 Type of study 
 Total number of GT participants included 
 Age, BMI/height/weight 
 Bilateral/unilateral symptoms 
 Diagnostic criteria for diagnosis of GT 
 Imaging used for confirming clinical diagnosis (if applicable) 
 Mean duration of symptoms 
 Outcome definitions –verbatim definitions of ‘what’ was measured e.g. pain, gait speed.  
 Outcome measurement instrument(s) – verbatim definitions of outcome measurement 
instruments used  
 How the outcome measurement instrument(s) was/were obtained 
 Outcome measurement time points 
 Intervention type  
 Whether assessment of validity of outcome measures used were reported, studied or absent 
 Whether reliability of the outcome measures used were reported, studied or absent 
This extraction framework will be tested by two members of the research team on a small sample of 
the included studies in order to ensure consistent application of the coding framework. Any 
questions arising during this testing process will be discussed by the team, and the data extraction 
framework revised accordingly.  
Two members of the team will then independently chart the data from each included study, 
following the agreed extraction framework. Early in this process, a small sample of the included 
articles independently reviewed will be compared by another member of the team (in order to 
ensure inter-rater reliability). Any discrepancies found in the extracted data will be discussed 
between the two reviewers until consensus is reached, or by arbitration of a third reviewer if 
necessary.  
Presentation of Results 
The results from this scoping search fulfil a first necessary step in the development of a COS for 
GT, within a five-stage process. The data collected from this scoping review will provide 
information on the scope and extent of outcome measures reported in the literature used in 
studies investigating GT. The outcome measures identified will be tabulated and matched to one 
of the previously established core domains for tendinopathy [10], as the next stage in the 
process. This information will be used to design an online Delphi survey in which an international 
panel of health care professionals (researchers and clinicians) and patients with GT will evaluate 
the Truth and Feasibility of the identified outcomes measures, before proceeding through the 
further stages of development. The results of this scoping review will be presented in an 
aggregate and visual form (using tables and charts, as appropriate), Figure 1 and Table 1.  
 Figure 1 PRISMA Diagram of Flow Through Study. This figure illustrates the process of identifying relevant outcome measures. 
  
Table 1 Summary of Outcome Measures Identified, their Reliability and Validity, and Draft Mapping to Core Tendon Domains. 
Clinical outcome 
measured, e.g. pain 
Outcome 
Measurement 
Instrument 
Reliability Validity Draft identification 
and mapping to core 
domain 
Pain VAS ICC: 0.98  Face, construct, criterion pain on activity/loading 
Pain NRS ICC: 0.96  Face, construct, criterion pain on activity/loading 
     
     
     
     
     
 
 APPENDIX 
Search Strategy for Selected Data Bases 
 
PubMed 
(“Gluteal tendinopathy" OR "Greater trochanteric pain syndrome" OR abductor tendinopathy OR 
"lateral hip pain" OR “trochanteric bursitis” OR (GTPS NOT (Guanosine-triphosphate OR "green tea" 
OR "grapevine trunk pathogens")) OR ((gluteal OR "gluteus medius" OR "gluteus minimus") AND 
(tendinitis OR tendonitis OR tendinosis OR tendinopathy OR “tendon pathology” OR enthesis OR 
enthesopathy OR tear OR tendon))) 
AND 
("therapy"[Subheading] OR "therapy"[All Fields] OR treat*[All Fields] OR "interventions" OR 
"intervention" OR "managements" OR "management" OR "manages" OR "managed" OR "manage" 
OR "rehabilitation"[Subheading] OR "rehabilitation"[All Fields] OR "rehabilitation"[MeSH Terms] OR 
"rehab"[All Fields] OR physiotherapy OR "physical therapy") 
 
EMBASE 
'gluteal tendinopathy'/exp OR 'gluteal tendinopathy' OR (gluteal AND ('tendinopathy'/exp OR 
tendinopathy)) 
OR 'greater trochanteric pain syndrome'/exp OR 'greater trochanteric pain syndrome' 
OR 'abductor tendinopathy' OR (abductor AND ('tendinopathy'/exp OR tendinopathy)) 
OR 'lateral hip pain' 
OR 'trochanteric bursitis'/exp OR 'trochanteric bursitis' OR (trochanteric AND ('bursitis'/exp OR 
bursitis)) 
OR gtps NOT ('guanosine triphosphate'/exp OR 'guanosine triphosphate' OR 'green tea'/exp OR 
'green tea' OR 'grapevine trunk pathogens') 
OR (gluteal OR 'gluteus medius' OR 'gluteus minimus') NEAR/4 (tendinitis OR tendonitis OR 
tendinosis OR 'tendon pathology' OR enthesis OR enthesopathy OR tear OR tendon) 
AND 
'therapy' OR treat* OR 'intervention'/exp OR intervention OR 'interventions'/exp OR interventions OR 
'management'/exp OR management OR managements OR manages OR managed OR manage OR 
'rehabilitation'/exp OR rehabilitation OR rehab OR 'physiotherapy'/exp OR physiotherapy OR 'physical 
therapy'/exp OR 'physical therapy' 
 
Scopus 
( ( "Gluteal tendinopathy"  OR  "Greater trochanteric pain syndrome"  OR  "abductor 
tendinopathy"  OR  "lateral hip pain"  OR  "trochanteric bursitis" )  OR  ( ( gtps )  AND 
NOT  ( guanosine-triphosphate  OR  "guanosine triphosphate"  OR  "green tea"  OR  "grapevine trunk 
pathogens" ) )  OR  ( ( gluteal  OR  "gluteus medius"  OR  "gluteus 
minimus" )  AND  ( tendinitis  OR  tendonitis  OR  tendinosis  OR  tendinopathy  OR  "tendon 
pathology"  OR  enthesis  OR  enthesopathy  OR  tear  OR  tendon ) ) )  AND  ( "therapy"  OR  treat*  
OR  "interventions"  OR  "intervention"  OR  "managements"  OR  "management"  OR  "manages"  O
R  "managed"  OR  "manage"  OR  "rehabilitation"  OR  "rehabilitation"  OR  "rehab"  OR  physiothera
py  OR  "physical therapy" )  
 
 
SPORTDiscus  
( "Gluteal tendinopathy" OR "Greater trochanteric pain syndrome" OR "abductor tendinopathy" OR 
"lateral hip pain" OR "trochanteric bursitis" ) 
OR gtps NOT ( guanosine-triphosphate OR "guanosine triphosphate" OR "green tea" OR "grapevine 
trunk pathogens" ) 
OR ( gluteal OR "gluteus medius" OR "gluteus minimus" ) AND ( tendinitis OR tendonitis OR 
tendinosis OR tendinopathy OR "tendon pathology" OR enthesis OR enthesopathy OR tear OR 
tendon )  
AND ( "therapy" OR treat* OR "interventions" OR "intervention" OR "managements" OR 
"management" OR "manages" OR "managed" OR "manage" OR "rehabilitation" OR "rehabilitation" 
OR "rehab" OR physiotherapy OR "physical therapy" )  
 
Grey Literature 
Proquest Dissertations and Theses Global; NICE; OpenGrey; Google; Pedro 
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